ALS TDI and Non-Profits Covering the Spectrum of Neurodegenerative Disease Collaborate on Key Disease Modeling Project

The Muscular Dystrophy Association, the Alzheimer’s Drug Development Foundation and The Association for Frontotemporal Degeneration are collaborating with the non-profit ALS biotech ALS TDI to support the detailed characterization of the TDP-43 mouse model of neurodegeneration. A thorough characterization of disease progression in TDP-43 mice at the molecular, anatomical, and behavioral levels will provide a solid basis from which critically needed protocols for predictive drug screening can be developed.

Click here to read more.

Share this: